A research team from the Dr. Rath Research Institute led by Dr. Aleksandra Niedzwiecki has demonstrated that a combination of specific micronutrients is able to significantly lower the number of receptors on human cells that are necessary for viral infection of the human body.
Ever since the angiotensin-converting enzyme 2 (ACE2) receptor was identified as the ‘entry door’ for coronaviruses to infect the human body, the race was on to ‘close this door’. One group of researchers embarked on the search for a vaccine to raise antibodies in the patient’s body that would be capable of blocking these ‘doors’. Another group of researchers chose a more direct approach: they tried to find ways to decrease the number of viral ‘doors’ expressed by down-regulating their production at the level of DNA.
Now a team of researchers from the Dr. Rath Research Institute may have won this race. They convincingly demonstrated that a defined combination of micronutrients, composed of bioactive natural molecules, is able to significantly lower the expression of ACE2 receptors in cell types preferentially affected by the coronavirus, the lung (epithelial) cells and vascular (endothelial) cells.